Clinical trial
Velcade in Myelodysplastic Syndrome - Pilot Study
NCT00440076 · Gruppo Italiano Malattie EMatologiche dell'Adulto, Other · Terminated
Key facts
| NCT number | NCT00440076 |
|---|---|
| Title | Velcade in Myelodysplastic Syndrome - Pilot Study |
| Official title | Phase II Study of PS341 (VELCADE) in Myelodysplastic Syndromes (MDS). EudraCT Number 2004-002935-23 |
| Lead sponsor | Gruppo Italiano Malattie EMatologiche dell'Adulto, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | MDS |
| Intervention type | Drug |
| Interventions | Velcade |
| Enrollment | 28 |
| Start date | Aug 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | Feb 26, 2007 |
| Last update posted | Apr 23, 2015 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: